Search Results - "Willems, Henriette M. G"
-
1
The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool Molecules
Published in Journal of medicinal chemistry (12-01-2023)“…Owing to their central role in regulating cell signaling pathways, the phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are attractive therapeutic targets…”
Get full text
Journal Article -
2
Systematic Investigation of the Permeability of Androgen Receptor PROTACs
Published in ACS medicinal chemistry letters (13-08-2020)“…Bifunctional molecules known as PROTACs simultaneously bind an E3 ligase and a protein of interest to direct ubiquitination and clearance of that protein, and…”
Get full text
Journal Article -
3
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2‑Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
Published in Journal of medicinal chemistry (28-04-2016)“…KEAP1 is the key regulator of the NRF2-mediated cytoprotective response, and increasingly recognized as a target for diseases involving oxidative stress…”
Get full text
Journal Article -
4
The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K)
Published in RSC medicinal chemistry (18-10-2023)“…The phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are therapeutic targets for diseases such as cancer, neurodegeneration and immunological disorders as…”
Get full text
Journal Article -
5
Structure–Activity and Structure–Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2‑Related Factor 2 (KEAP1/NRF2) Protein–Protein Interaction
Published in Journal of medicinal chemistry (09-05-2019)“…The KEAP1–NRF2-mediated cytoprotective response plays a key role in cellular homoeostasis. Insufficient NRF2 signaling during chronic oxidative stress may be…”
Get full text
Journal Article -
6
Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein−Protein Interaction
Published in Journal of medicinal chemistry (11-11-2021)“…The NRF2-mediated cytoprotective response is central to cellular homoeostasis, and there is increasing interest in developing small-molecule activators of this…”
Get full text
Journal Article -
7
Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor
Published in RSC medicinal chemistry (25-05-2023)“…The phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) play a central role in regulating cell signalling pathways and, as such, have become therapeutic…”
Get full text
Journal Article -
8
Small-Molecule Inhibitors of the MDM2-p53 Protein−Protein Interaction Based on an Isoindolinone Scaffold
Published in Journal of medicinal chemistry (19-10-2006)“…From a set of weakly potent lead compounds, using in silico screening and small library synthesis, a series of 2-alkyl-3-aryl-3-alkoxyisoindolinones has been…”
Get full text
Journal Article -
9
Development of Selective Phosphatidylinositol 5‑Phosphate 4‑Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode
Published in Journal of medicinal chemistry (24-02-2022)“…Phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are emerging as attractive therapeutic targets in diseases, such as cancer, immunological disorders, and…”
Get full text
Journal Article -
10
Disease phenotypic screening in neuron-glia cocultures identifies blockers of inflammatory neurodegeneration
Published in iScience (19-04-2024)“…Neuropathology is often mediated by interactions between neurons and glia that cannot be modeled by monocultures. However, cocultures are difficult to use and…”
Get full text
Journal Article -
11
Generation and Selection of Novel Estrogen Receptor Ligands Using the De Novo Structure-Based Design Tool, SkelGen
Published in Journal of chemical information and modeling (01-03-2006)“…A de novo design approach to generating novel estrogen receptor (ER) ligands is described. The SkelGen program was used to generate ligands in the active sites…”
Get full text
Journal Article -
12
De Novo Ligand Design to Partially Flexible Active Sites: Application of the ReFlex Algorithm to Carboxypeptidase A, Acetylcholinesterase, and the Estrogen Receptor
Published in Journal of chemical information and modeling (01-02-2008)“…Reflex is a recent algorithm in the de novo ligand design software, SkelGen, that allows the flexibility of amino acid side chains in a protein to be taken…”
Get full text
Journal Article -
13
Receptor Flexibility in the in Silico Screening of Reagents in the S1‘ Pocket of Human Collagenase
Published in Journal of medicinal chemistry (20-05-2004)“…A major difficulty in structure-based molecular design is the prediction of the structure of the protein−ligand complex because of the enormous number of…”
Get full text
Journal Article -
14
Isoindolinone-based inhibitors of the MDM2–p53 protein–protein interaction
Published in Bioorganic & medicinal chemistry letters (01-03-2005)“…The design, synthesis and evaluation of 24 isoindolinones as potential inhibitors of the MDM2–p53 interaction is described. The most potent inhibitor NU8231…”
Get full text
Journal Article -
15
SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for Ligand-Based Drug Design
Published 03-10-2024“…Drug discovery is a complex and resource-intensive process, with significant time and cost investments required to bring new medicines to patients. Recent…”
Get full text
Journal Article